Get the latest Science News and Discoveries

Phase two CD19-antibody-drug conjugate trial demonstrates promise for aggressive lymphoma

None

Get the Android app

Or read this on Eureka Alert

« Bio-based coating for wood outperforms traditional synthetic options

Novel imaging agent identifies biomarker for iron-targeted cancer therapies »